Aier Eye Hospital Group Co., Ltd. (SHE:300015)
China · Delayed Price · Currency is CNY | Market Cap | 98.05B -16.8% |
| Revenue (ttm) | 22.72B +4.2% |
| Net Income | 3.37B -9.0% |
| EPS | 0.36 -9.3% |
| Shares Out | 9.29B |
| PE Ratio | 29.03 |
| Forward PE | 23.71 |
| Dividend | 0.20 (1.90%) |
| Ex-Dividend Date | Jan 15, 2026 |
| Volume | 68,515,636 |
| Average Volume | 99,530,437 |
| Open | 10.51 |
| Previous Close | 10.54 |
| Day's Range | 10.49 - 10.73 |
| 52-Week Range | 9.32 - 13.95 |
| Beta | 0.55 |
| RSI | 57.27 |
| Earnings Date | Apr 24, 2026 |
About Aier Eye Hospital Group
Aier Eye Hospital Group Co., Ltd. operates as an ophthalmic medical company in China, Hong Kong, Europe, the United States, Europe, and Southeast Asia. It offers diagnosis and treatment of various ophthalmic diseases, surgical services, medical optometry, and lens fitting for fundus diseases, glaucoma, and cataract. The company also provides training courses for cataract cases, ICL surgery, and presbyopia surgery. Aier Eye Hospital Group Co., Ltd. was founded in 2002 and is headquartered in Changsha, China [Read more]
Financial Performance
In 2025, Aier Eye Hospital Group's revenue was 22.35 billion, an increase of 6.53% compared to the previous year's 20.98 billion. Earnings were 3.24 billion, a decrease of -8.88%.
Financial StatementsNews
Aier Eye Seeks Hong Kong Listing For International Growth
The leading Chinese chain of private eye hospitals is aiming to boost its brand visibility and widen its funding options, but will it be able to justify a juicy premium? image credit: Bamboo Works Key...